Results can be long-lasting with ongoing treatment and appropriate lifestyle changes
SURMOUNT-1 (tirzepatide) data SURMOUNT-1 (N=2,539) tested tirzepatide 5, 10, and 15 mg against placebo over 72 weeks, reporting 15.0%, 19.5%, and 20.9% mean weight loss at the three doses respectively [2]
Thats rare in this space and signals real confidence in the product
Once an individual stops taking Semaglutide GLP-1, it is possible that they may regain some or all of the weight lost during the treatment
These changes interact with sleep in important ways that deserve attention for optimal results
The result is a lightweight, stable powder that is ideal for long-term storage